HOMENewsResults of A First-in-Human Study for New Application of Photodynamic Therapy with 5-Aminolevulinic Acid for Extracorporeal Photopheresis Published in “Pharmaceutics”(SBI Holdings, photonamic)
Group company news
Results of A First-in-Human Study for New Application of Photodynamic Therapy with 5-Aminolevulinic Acid for Extracorporeal Photopheresis Published in “Pharmaceutics” (SBI Holdings, photonamic)
